198 related articles for article (PubMed ID: 29540104)
21. Stability study of carboplatin infusion solutions in 0.9% sodium chloride in polyvinyl chloride bags.
Myers AL; Zhang YP; Kawedia JD; Trinh VA; Tran H; Smith JA; Kramer MA
J Oncol Pharm Pract; 2016 Feb; 22(1):31-6. PubMed ID: 25122633
[TBL] [Abstract][Full Text] [Related]
22. Activity of infusional etoposide, vincristine, and doxorubicin with bolus cyclophosphamide (EPOCH) in relapsed Hodgkin's disease.
Stokoe CT; Ogden J; Jain VK
Oncologist; 2001; 6(5):428-34. PubMed ID: 11675520
[TBL] [Abstract][Full Text] [Related]
23. Comparison of costs for infusion versus bolus chemotherapy administration: analysis of five standard chemotherapy regimens in three common tumors--Part one. Model projections for cost based on charges.
Lokich JJ; Moore CL; Anderson NR
Cancer; 1996 Jul; 78(2):294-9. PubMed ID: 8674006
[TBL] [Abstract][Full Text] [Related]
24. Compatibility and stability of paclitaxel combined with doxorubicin hydrochloride in infusion solutions.
Trissel LA; Xu QA; Gilbert DL
Ann Pharmacother; 1998 Oct; 32(10):1013-6. PubMed ID: 9793591
[TBL] [Abstract][Full Text] [Related]
25. Chemotherapy with etoposide, vincristine, doxorubicin, bolus cyclophosphamide, and oral prednisone in patients with refractory cutaneous T-cell lymphoma.
Akpek G; Koh HK; Bogen S; O'Hara C; Foss FM
Cancer; 1999 Oct; 86(7):1368-76. PubMed ID: 10506727
[TBL] [Abstract][Full Text] [Related]
26. Protocol for a randomised crossover trial to evaluate patient and nurse satisfaction with electronic and elastomeric portable infusion pumps for the continuous administration of antibiotic therapy in the home: the Comparing Home Infusion Devices (CHID) study.
Hobbs JG; Ryan MK; Ritchie B; Sluggett JK; Sluggett AJ; Ralton L; Reynolds KJ
BMJ Open; 2017 Jul; 7(7):e016763. PubMed ID: 28760798
[TBL] [Abstract][Full Text] [Related]
27. Role of a doxorubicin-containing regimen in relapsed and resistant lymphomas: an 8-year follow-up study of EPOCH.
Gutierrez M; Chabner BA; Pearson D; Steinberg SM; Jaffe ES; Cheson BD; Fojo A; Wilson WH
J Clin Oncol; 2000 Nov; 18(21):3633-42. PubMed ID: 11054436
[TBL] [Abstract][Full Text] [Related]
28. Compatibility and stability of vincristine sulfate, doxorubicin hydrochloride, and etoposide phosphate in 0.9% sodium chloride injection.
Yuan P; Grimes GJ; Shankman SE; Daniels CE; Goldspiel BR; Potti GK
Am J Health Syst Pharm; 2001 Apr; 58(7):594-8. PubMed ID: 11296609
[No Abstract] [Full Text] [Related]
29. An investigation of the stability of meropenem in elastomeric infusion devices.
Foy F; Luna G; Martinez J; Nizich Z; Seet J; Lie K; Sunderland B; Czarniak P
Drug Des Devel Ther; 2019; 13():2655-2665. PubMed ID: 31447546
[TBL] [Abstract][Full Text] [Related]
30. Stability of colistimethate sodium in a disposable elastomeric infusion device.
Abdulla A; van Leeuwen RW; de Vries Schultink AH; Koch BC
Int J Pharm; 2015; 486(1-2):367-9. PubMed ID: 25863116
[TBL] [Abstract][Full Text] [Related]
31. Stability of meropenem in portable elastomeric infusion devices: which protocol should be implemented in clinical practice?
Esteban-Cartelle B; Serrano DR; Pérez Menéndez-Conde C; Vicente-Oliveros N; Álvarez-Díaz A; Fortún Abete J; Martín-Dávila P
Microbiol Spectr; 2024 Jan; 12(1):e0206423. PubMed ID: 38088799
[TBL] [Abstract][Full Text] [Related]
32. Physical and Chemical Stability of Urapidil in 0.9% Sodium Chloride in Elastomeric Infusion Pump.
Tomasello C; Leggieri A; Rabbia F; Veglio F; Baietto L; Fulcheri C; De Nicolò A; De Perri G; D'Avolio A
Int J Pharm Compd; 2016; 20(4):343-346. PubMed ID: 28333680
[TBL] [Abstract][Full Text] [Related]
33. Dose-Adjusted Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Doxorubicin (EPOCH) With or Without Rituximab as First-Line Therapy for Aggressive Non-Hodgkin Lymphoma.
Lamar ZS; Fino N; Palmer J; Gruber L; Morris BB; Raetskaya-Solntseva O; Kennedy L; Vaidya R; Hurd D; Zamkoff K
Clin Lymphoma Myeloma Leuk; 2016 Feb; 16(2):76-81. PubMed ID: 26725264
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetic comparison of oral and intravenous etoposide in patients treated with the CHOEP-regimen for malignant lymphomas.
Kroschinsky FP; Friedrichsen K; Mueller J; Pursche S; Haenel M; Prondzinsky R; Ehninger G; Schleyer E
Cancer Chemother Pharmacol; 2008 Apr; 61(5):785-90. PubMed ID: 17579865
[TBL] [Abstract][Full Text] [Related]
35. A phase II trial of combination chemotherapy and surgical resection for the treatment of metastatic adrenocortical carcinoma: continuous infusion doxorubicin, vincristine, and etoposide with daily mitotane as a P-glycoprotein antagonist.
Abraham J; Bakke S; Rutt A; Meadows B; Merino M; Alexander R; Schrump D; Bartlett D; Choyke P; Robey R; Hung E; Steinberg SM; Bates S; Fojo T
Cancer; 2002 May; 94(9):2333-43. PubMed ID: 12015757
[TBL] [Abstract][Full Text] [Related]
36. Temperature profiles of antibiotic-containing elastomeric infusion devices used by ambulatory care patients.
Docherty T; Montalto M; Leslie J; King K; Niblett S; Garrett T
Am J Health Syst Pharm; 2017 Jul; 74(13):992-1001. PubMed ID: 28645997
[TBL] [Abstract][Full Text] [Related]
37. Physical and chemical stability of a generic etoposide formulation as an alternative to etoposide phosphate.
Sadou Yayé H; Hassani L; Secrétan PH; Babiard M; Aouati H; Bellanger A; Tilleul P; Yagoubi N; Do B; Rietveld IB
J Pharm Biomed Anal; 2020 Jan; 178():112896. PubMed ID: 31600662
[TBL] [Abstract][Full Text] [Related]
38. Chemical and physical stability of etoposide and teniposide in commonly used infusion fluids.
Beijnen JH; Beijnen-Bandhoe AU; Dubbelman AC; van Gijn R; Underberg WJ
J Parenter Sci Technol; 1991; 45(2):108-12. PubMed ID: 2051255
[TBL] [Abstract][Full Text] [Related]
39. A phase I study of etoposide phosphate plus paclitaxel.
Brooks DJ; Alberts DS
Semin Oncol; 1996 Dec; 23(6 Suppl 13):30-3. PubMed ID: 8996573
[TBL] [Abstract][Full Text] [Related]
40. Phase I study of high-dose etoposide phosphate in man.
Fields SZ; Budman DR; Young RR; Kreis W; Ingram R; Schulman P; Cherny RC; Wright J; Behr J; Snow C; Schacter LP
Bone Marrow Transplant; 1996 Nov; 18(5):851-6. PubMed ID: 8932836
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
